Subscribe to Newsletter

Business & Regulation

 Business & Regulation Formulation

Compounders Confounded

| Rob Coker

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

Business & Regulation Trends & Forecasts

A Decade of Transformative Treatments

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.
Business & Regulation Trends & Forecasts

Celebrating the final day of CPhI Europe

| Rob Coker

The highlights of the trade show and its conference agenda - day 3
Business & Regulation Trends & Forecasts

CPhI Europe continues Today in Milan

| Rob Coker

The highlights of the trade show and its conference agenda - day 2
Business & Regulation Trends & Forecasts

Welcome to CPhI Europe!

| Rob Coker

The highlights of the trade show and its conference agenda - day 1
Business & Regulation Standards & Regulation

FDA Warning Letters: September 2024 Edition

| Stephanie Vine | 3 min read

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.
Business & Regulation Trends & Forecasts

Innovate, Collaborate, and Make Medicines Accessible

Michael Altorfer, CEO, Swiss Biotech Association, gives his view on the future of drug development.
Business & Regulation Trends & Forecasts

The Multifaceted Future of Pharma

| Stephanie Vine

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.
Business & Regulation Business Practice

Driving the Future of Biopharma

| Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.
Business & Regulation Profession

Words of Wisdom

| Stephanie Vine

A look back at some of the most inspiring quotes from our interviews.
Business & Regulation Standards & Regulation

AstraZeneca Flu Vaccine Approved For Self-Administration

| Rob Coker

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.
Business & Regulation Supply Chain

Towards More Resilient Supply

| 5 min read

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?
Business & Regulation Trends & Forecasts

The Building Blocks of Engagement

| Aaron Bean | 3 min read

Shifting trends demand a change in how pharma field reps interact with healthcare professionals
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker